Cargando…

Clinical Outcome of Acquired Post-Immunosuppressive-Therapy Aplastic Anemia in Pediatric Patients: A 13-Year Experience in Two Southern China Tertiary Care Centers

OBJECTIVE: The aim of the present study is to evaluate the efficacy, complications, and contributing factors of immunosuppressive therapy (IST) response in children with acquired aplastic anemia (AA) and to explore optimal therapeutic methods for different clinical AA types. METHODS: A total of 130...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Junbin, Huang, Lifen, Liu, Su, Lin, Shaofen, Cheng, Yucai, Jiang, Xiaoyun, Xue, Hongman, Li, Chikong, Chen, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259937/ https://www.ncbi.nlm.nih.gov/pubmed/34239322 http://dx.doi.org/10.2147/IJGM.S313898

Ejemplares similares

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

Single-cell RNA sequencing depicts metabolic changes in children with aplastic anemia
por: Zhou, Qin, et al.
Publicado: (2023)

Population Pharmacokinetics of Cyclosporine in Chinese Pediatric Patients With Acquired Aplastic Anemia
por: Gao, Xuan, et al.
Publicado: (2022)

Gut inflammation in the pathogenesis of acquired aplastic anemia
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis
por: Zhu, Yangmin, et al.
Publicado: (2020)

Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2015)

Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
por: Zaimoku, Yoshitaka, et al.
Publicado: (2021)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

THPO gene variants in patients with acquired aplastic anemia
por: Padilha, Pedro Henrique, et al.
Publicado: (2018)

Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
por: Shah, Sandip, et al.
Publicado: (2018)

Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapy
por: de Castro, Murilo Antunes, et al.
Publicado: (2011)

Risk factors associated with poor response to immunosuppressive therapy in acquired aplastic anemia: A meta-analysis of retrospective studies
por: Wang, Jia, et al.
Publicado: (2020)

Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
por: Medinger, Michael, et al.
Publicado: (2018)

Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia
por: Lan, Yang, et al.
Publicado: (2021)

First-Line Matched Related Donor Hematopoietic Stem Cell Transplantation Compared to Immunosuppressive Therapy in Acquired Severe Aplastic Anemia
por: Peinemann, Frank, et al.
Publicado: (2011)

Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report
por: Matsui, Kenji, et al.
Publicado: (2022)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
por: Ranjit Kumar, C., et al.
Publicado: (2022)

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
por: Goronkova, Olga, et al.
Publicado: (2022)

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
por: Contejean, Adrien, et al.
Publicado: (2019)

Acquired Aplastic Anemia in Immunocompetent Pediatric Patients with Asymptomatic COVID-19 Infection: A Case Series
por: Fritch, Jordan E., et al.
Publicado: (2021)

Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia
por: Chen, Lingyun, et al.
Publicado: (2023)

Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes
por: Giudice, Valentina, et al.
Publicado: (2018)

Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells
por: Brzeźniakiewicz-Janus, Katarzyna, et al.
Publicado: (2020)

Assessment of Hepatic Profile in Acquired Aplastic Anemia: An Experience From Pakistan
por: Thakur, Warkha, et al.
Publicado: (2022)

Acquired aplastic anemia following SARS‐CoV‐2 vaccination
por: Röth, Alexander, et al.
Publicado: (2022)

Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis
por: Zhang, Meng-Xue, et al.
Publicado: (2021)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia
por: Chen, Cunte, et al.
Publicado: (2023)

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
por: Huo, Jiali, et al.
Publicado: (2020)

Response of Eltrombopag in immune thrombocytopenia and acquired idiopathic aplastic anemia: A single-center experience
por: Abbasi, Abdul Muqtadir, et al.
Publicado: (2022)

PB1940: ACQUIRED APLASTIC ANEMIA: THE CHALLENGE OF TREATMENT IN MEXICO. SINGLE HEMATOLOGY CENTER EXPERIENCE
por: Guajardo Leal, M. L., et al.
Publicado: (2022)

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia
por: Wang, Shichong, et al.
Publicado: (2023)

Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022)

Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults
por: Lee, Ji Hyun, et al.
Publicado: (2010)

Acquired aplastic anemia associated with trisomy eight converting into acute myeloid leukemia
por: Grover, Sumit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m08qb9fev5hff27ut181g7lehd